JSSH
RVMD icon

J. Safra Sarasin Holding’s Revolution Medicines RVMD Stock Holding History

J. Safra Sarasin Holding’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
8,007
-12,994
-62% -$1.9M 0.02% 315
2026
Q1 		$2.04M Buy
21,001
+13,235
+170% +$1.34M 0.03% 200
2025
Q4 		$619K Buy
+7,766
New +$509K 0.01% 373

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

J. Safra Sarasin Holding's RVMD Position: Q2 2026 in Review

J. Safra Sarasin Holding reduced its Revolution Medicines (RVMD) stake by 62% in Q2 2026, selling an estimated $1.9M and leaving 8,007 shares worth $1.5M. The position accounts for 0.02% of the portfolio, ranked #315.

J. Safra Sarasin Holding first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.04M in Q1 2026. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • J. Safra Sarasin Holding held 8,007 shares of Revolution Medicines worth $1.5M as of Q2 2026.
  • J. Safra Sarasin Holding sold 12,994 Revolution Medicines shares in Q2 2026, an estimated $1.9M.
  • Revolution Medicines made up 0.02% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #315 holding.
  • J. Safra Sarasin Holding first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • J. Safra Sarasin Holding's Revolution Medicines position peaked at $2.04M in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.